NCT06308393View on ClinicalTrials.gov

Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

HealthyPsoriatic Subjects

Interventions

DRUG

RSS0393 ointment；Placebo

RSS0393 ointment；RSS0393 ointment placebo

Trial Locations (2)

200040

The First Affiliated Hospital of University of Science and Technology of China (USTC)., Hefei

230000

Huashan Hospital Affiliated to Fudan University, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT06308393 - Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects | Biotech Hunter | Biotech Hunter